We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$209M
2
KSU
Kansas City Southern
KSU
+$193M
3
HWM icon
Howmet Aerospace
HWM
+$184M
4
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$172M
5
TMUS icon
T-Mobile US
TMUS
+$160M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.42B
2
MXIM
Maxim Integrated Products
MXIM
+$476M
3
WTW icon
Willis Towers Watson
WTW
+$468M
4
WORK
Slack Technologies, Inc.
WORK
+$462M
5
AON icon
Aon
AON
+$371M

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 13.3%
3 Industrials 11.55%
4 Communication Services 11.47%
5 Financials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LGV.WS
276
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$79K ﹤0.01%
60,940
– –
NDACW
277
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
$68K ﹤0.01%
80,000
– –
GIIXW
278
DELISTED
Gores Holdings VIII, Inc. Warrant
GIIXW
$57K ﹤0.01%
50,000
– –
GTPAW
279
DELISTED
Gores Technology Partners, Inc. Warrant
GTPAW
$56K ﹤0.01%
50,000
– –
SVFAW
280
DELISTED
SVF Investment Corp. Warrant
SVFAW
$50K ﹤0.01%
50,000
– –
LGACW
281
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$49K ﹤0.01%
60,000
– –
TMAC.WS
282
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$47K ﹤0.01%
62,500
– –
LOKM.WS
283
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
$46K ﹤0.01%
50,000
– –
HIIIW
284
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$41K ﹤0.01%
50,000
– –
RGTIW icon
285
Rigetti Computing Warrants
RGTIW
$178M
$40K ﹤0.01%
50,000
– –
ANAC.WS
286
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$37K ﹤0.01%
50,000
– –
AEON.WS
287
DELISTED
AEON Biopharma Inc
AEON.WS
$29K ﹤0.01%
49,995
– –
LDHAW
288
DELISTED
LDH Growth Corp I Warrant
LDHAW
$23K ﹤0.01%
30,000
– –
ASPCW
289
DELISTED
Alpha Capital Acquisition Co Warrant
ASPCW
$22K ﹤0.01%
39,799
– –
RUMBW
290
RUM Group Inc Warrant
RUMBW
$16.1M
$20K ﹤0.01%
25,000
– –
NSTC.WS
291
DELISTED
Northern Star Investment Corp. III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTC.WS
$17K ﹤0.01%
16,667
– –
SLAMW
292
DELISTED
Slam Corp. warrant
SLAMW
$16K ﹤0.01%
17,627
– –
NSTD.WS
293
DELISTED
Northern Star Investment Corp. IV Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTD.WS
$15K ﹤0.01%
16,666
– –
APLS
294
DELISTED
Apellis Pharmaceuticals
APLS
– –
-1,550,000
Closed -$98M
ASND icon
295
Ascendis Pharma A/S
ASND
$16.6B
– –
-375,000
Closed -$49.3M
GOSS icon
296
Gossamer Bio
GOSS
$75.6M
– –
-202,326
Closed -$1.64M
HIG icon
297
Hartford Financial Services
HIG
$36.9B
– –
-150,000
Closed -$9.3M
KRYS icon
298
Krystal Biotech
KRYS
$10.3B
– –
-75,000
Closed -$5.1M
KURA icon
299
Kura Oncology
KURA
$1.06B
– –
-200,000
Closed -$4.17M
PHVS icon
300
Pharvaris
PHVS
$2.55B
– –
-71,020
Closed -$1.29M
9 10 11
12
13

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2021 Portfolio in Review

As of Q3 2021, Thomas Steyer held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Thomas Steyer withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Thomas Steyer opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Thomas Steyer's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Thomas Steyer added most to Aramark in Q3 2021, an estimated $209M increase.
  • Thomas Steyer's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Thomas Steyer fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Thomas Steyer's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Thomas Steyer opened 40 new positions and closed 34 in Q3 2021.
  • Thomas Steyer's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.